360° SearchNetwork Hot Spots Trends Time Series

Medifocus Inc

Type: Company

Name: Medifocus Inc

First reported Apr 29 2013 - Updated Apr 29 2013 - 1 reports

Monday Deal Review: April 29, 2013

Welcome to your Monday Biotech Deal Review for April 29, 2013! This week saw Ergoresearch and Amorfix close their previously announced private offerings. Trimel, meanwhile, has raised $40 million from their public offering of 50,000,000 common shares. ... [Published The Cross-Border Biotech Blog - Apr 29 2013]

Entities: Cardiome Pharma Corp, Amorfix Life Sciences Ltd, Neovasc Inc, Ergoresearch Ltd

First reported Mar 18 2013 - Updated Mar 18 2013 - 1 reports

Medifocus closes shares-for-debt settlement

Medifocus Inc. has completed the share-for-debt transaction originally announced Jan. 29, 2013. The company issued today an aggregate of 1.09 million common shares at a deemed price of 25 cents per common share to settle an aggregate of $272,500 of debt, ... [Published Stockwatch - Mar 18 2013]

Entities: Medifocus Inc, Common Shares

First reported Mar 01 2013 - Updated Mar 01 2013 - 1 reports

Toronto stock exchange

Medifocus 1.09 million shares for debts

Medifocus Inc Symbol C : MFS Shares Issued 116,170,411 Close 2013-02-27 C$ 0.25 Recent Sedar DocumentsView Original Document The TSX Venture Exchange has accepted for filing the company's proposal to issue 1.09 million common shares at a deemed value ... [Published Stockwatch - Mar 01 2013]

Entities: Medifocus Inc, Common Shares, Toronto stock exchange

First reported Jan 21 2013 - Updated Jan 21 2013 - 1 reports

YM Biosciences Inc

Monday Deal Review: January 21, 2013

Welcome to your Monday Biotech Deal Review for January 21, 2013! Medicago made news last week with a $15 million loan agreement with an unnamed pharmaceutical company. The funds are being used for Medicago’s plant-based VLP vaccine pipeline. As the ... [Published The Cross-Border Biotech Blog - Jan 21 2013]

Entities: Medicago Inc, Toronto stock exchange, Paladin Labs Inc, YM Biosciences Inc

First reported Dec 17 2012 - Updated Dec 17 2012 - 1 reports

Gilead Sciences Inc

Monday Deal Review: December 17, 2012

Welcome to your Monday Biotech Deal Review for December 17, 2012. This week saw the completion of a number of previously announced acquisitions, as well as the announcement of new ones. The latter group includes Gilead’s acquisition of YM Biosciences ... [Published The Cross-Border Biotech Blog - Dec 17 2012]

Entities: Toronto stock exchange, Gilead Sciences Inc, Patheon Inc, Acquisition

Quotes

...Augustine Cheung, chief executive officer of Medifocus, commented: "These obligations were accrued at a time when the company was somewhat cash constrained. It is an indication of confidence in the company's future that management and vendors choose to convert their accrued obligations into stock in the company."

Medifocus closes shares-for-debt settlement [Published Stockwatch - Mar 18 2013]

More Content

sort by: Date \| Relevance
Monday Deal Review: April 29, 2013 [Published The Cross-Border Biotech Blog - Apr 29 2013]
Medifocus Inc. Announces Extension of Warrants [Published Marketwire - Breaking News Releases - Apr 24 2013]
Monday Deal Review: March 25, 2013 [Published The Cross-Border Biotech Blog - Mar 25 2013]
Medifocus closes shares-for-debt settlement [Published Stockwatch - Mar 18 2013]
Medifocus, Inc. Announces Completion of Shares ... [Published Marketwire - Breaking News Releases - Mar 18 2013]
Medifocus 1.09 million shares for debts [Published Stockwatch - Mar 01 2013]
Medifocus, Inc. Obtains New US Patent Covering ... [Published Marketwire - Breaking News Releases - Feb 25 2013]
Monday Deal Review: February 18, 2013 [Published The Cross-Border Biotech Blog - Feb 18 2013]
Medifocus Inc. Awarded Position on the 2013 TSX... [Published Marketwire - Breaking News Releases - Feb 14 2013]
Monday Deal Review: February 4, 2013 [Published The Cross-Border Biotech Blog - Feb 04 2013]
Medifocus Inc. Announces Shares for Debt Transa... [Published Marketwire - Breaking News Releases - Jan 29 2013]
Medifocus Inc. Announces the Acceleration of Pr... [Published Marketwire - Breaking News Releases - Jan 23 2013]
Monday Deal Review: January 21, 2013 [Published The Cross-Border Biotech Blog - Jan 21 2013]
Medifocus Inc. Announces Closing of Private Pla... [Published Marketwire - Breaking News Releases - Jan 14 2013]
Medifocus Inc. Announces Stock Option Grants an... [Published Marketwire - Breaking News Releases - Dec 17 2012]
Monday Deal Review: December 17, 2012 [Published The Cross-Border Biotech Blog - Dec 17 2012]
Medifocus Inc. Announces Increase in Size of Un... [Published Marketwire - Breaking News Releases - Dec 11 2012]
Monday Deal Review: December 10, 2012 [Published The Cross-Border Biotech Blog - Dec 10 2012]
Medifocus Inc. Announces Units Offering [Published Marketwire - Breaking News Releases - Nov 30 2012]

Blogs

sort by: Date \| Relevance
Monday Deal Review: April 29, 2013 [Published The Cross-Border Biotech Blog - Apr 29 2013] Welcome to your Monday Biotech Deal Review for April 29, 2013! This week saw Ergoresearch and Amorfix close their previously announced private offerings. Trimel, meanwhile, has raised $40 million from their public offering of 50,000,000 common shares. ...
Monday Deal Review: March 25, 2013 [Published The Cross-Border Biotech Blog - Mar 25 2013] Welcome to your Monday Biotech Deal Review for March 25, 2013! This week’s big news was Valeant’s ongoing strategy of using acquisitions to bolster their product portfolio rather than R&D. Valeant is paying US$19.75 per share of Obagi, which is a skin-care ...
Monday Deal Review: February 18, 2013 [Published The Cross-Border Biotech Blog - Feb 18 2013] Welcome to your Monday Biotech Deal Review for February 18, 2013! This week saw Gilead finally close its acquisition of YM Biosciences, with YM’s shares now de-listed from trading on the NYSE Amex and the TSX. Shareholders were given $2.65 for each ...
Monday Deal Review: February 4, 2013 [Published The Cross-Border Biotech Blog - Feb 04 2013] Welcome to your Monday Biotech Deal Review for February 4, 2013! This week saw significant activity in the sector generally On the M&A side, Valeant continued their ongoing acquisition strategy, buying the Russian Natur Product International, a primarily ...
Monday Deal Review: January 21, 2013 [Published The Cross-Border Biotech Blog - Jan 21 2013] Welcome to your Monday Biotech Deal Review for January 21, 2013! Medicago made news last week with a $15 million loan agreement with an unnamed pharmaceutical company. The funds are being used for Medicago’s plant-based VLP vaccine pipeline. As the ...

Press Releases

sort by: Date \| Relevance
Medifocus Inc. Announces Extension of Warrants [Published Marketwire - Breaking News Releases - Apr 24 2013]
Medifocus, Inc. Announces Completion of Shares ... [Published Marketwire - Breaking News Releases - Mar 18 2013]
Medifocus, Inc. Obtains New US Patent Covering ... [Published Marketwire - Breaking News Releases - Feb 25 2013]
Medifocus Inc. Awarded Position on the 2013 TSX... [Published Marketwire - Breaking News Releases - Feb 14 2013]
Medifocus Inc. Announces Shares for Debt Transa... [Published Marketwire - Breaking News Releases - Jan 29 2013]